Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicentre Randomized Controlled Trial of the Use of Extended Peri-Operative Low Molecular Weight Heparin to Improve Cancer Specific Survival Following Surgical Resection of Colon Cancer

Next Previous
X
Search
Trial Profile

A Multicentre Randomized Controlled Trial of the Use of Extended Peri-Operative Low Molecular Weight Heparin to Improve Cancer Specific Survival Following Surgical Resection of Colon Cancer

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 25 Jan 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tinzaparin sodium (Primary)
  • Indications Adenocarcinoma; Cancer metastases; Colon cancer; Colorectal cancer; Deep vein thrombosis; Pulmonary embolism; Rectal cancer; Venous thromboembolism
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms PERIOP-01

    • Most Recent Events

    • 12 Dec 2023 Results of post hoc analysis (n=614) assessing Efficacy and Safety of Extended Duration Postoperative Thromboprophylaxis with Low-Molecular-Weight-Heparin Among Subgroups of Patients Undergoing Surgical Resection of Colorectal Cancer presented at the 65th American Society of Hematology Annual Meeting and Exposition
    • 20 Sep 2022 Primary endpoint has not been met (Disease Free Survival), as per Results published in the BMJ
    • 20 Sep 2022 Results published in the BMJ

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top